The pharmaceutical industry is warning that estrogen patches continue to be in shortage in the U.S. as manufacturers struggle to keep up with increased demand linked to federal policy changes issued earlier this year, even as regulators have yet to recognize a lack in supply. Manufacturers first reported issues with supplying demand earlier this year...
The pharmaceutical industry is warning that estrogen patches continue to be in shortage in the U.S. as manufacturers struggle to keep up with increased demand linked to federal policy changes issued earlier this year, even as regulators have yet to recognize a lack in supply. Manufacturers first reported issues with supplying demand earlier this year...
<iframe src="https://statesidedaily.com/embed/cluster/d349bdb75aaaaf8502bf739d5aaa5ef98d900b14" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Drugmakers still struggling to keep up with spiking estrogen patch demand"></iframe>
